LE
No verificado

LEO Pharma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud
21/01/2026
Salud
Ciencia
Farmacéutica
Medicina - Varios
Industria
LEO Pharma advances Anzupgo® (delgocitinib) cream to phase 3 trial in lichen sclerosus (LS)
1.00
07/01/2026
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Sanidad
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
1.00
16/12/2025
Mercado laboral
Salud
Sanidad
Ciencia
Medicina - Varios
Farmacéutica
LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
1.00
15/12/2025
Industria
Salud
Sanidad
Ciencia
Medicina - Varios
Farmacéutica
LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA
1.00
17/11/2025
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
LEO Pharma Announces Positive Topline 32-Week Key Results in ADHAND Trial
1.00
06/11/2025
Mercado de valores
Biotecnología
Sanidad
Farmacéutica
Salud
LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
1.00
05/11/2025
Biotecnología
Sanidad
Farmacéutica
Salud
Industria
LEO Pharma Announces NICE Recommendation of Reimbursement in England and Wales
1.00
21/10/2025
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
LEO Pharma Reinforces Leadership in Medical Dermatology with New Data from Across Its Portfolio at 2025 Fall Clinical Dermatology Conference
1.00

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0